Recent Developments in Dementia Treatment

The Food and Drug Administration (FDA) has recently granted full approval to a novel Alzheimer's treatment known as lecanemab. This medication has demonstrated the ability to moderately decelerate cognitive and functional decline in individuals with early-stage Alzheimer's disease. It received traditional approval from the US FDA for Alzheimer's disease treatment based on Phase 3 data derived from the Clarity AD clinical trial. Additionally, recent research suggests that older individuals with higher levels of triglycerides, a type of fat in the bloodstream, may experience a reduced risk of dementia and a slower cognitive decline over time when compared to those with lower triglyceride levels.

    Related Conference of Recent Developments in Dementia Treatment

    December 11-12, 2023

    5th World Brain Congress

    Rome, Italy
    February 01-02, 2024

    33rd world congress on Neurology and Therapeutics

    Dubai, UAE
    February 08-09, 2024

    4th Annual Dementia Congress

    Paris, France
    February 08-09, 2024

    5th Global Summit on Brain Disorders and Therapeutics

    Madrid, Spain
    February 08-09, 2024

    6th World Depression Congress

    Paris, France
    March 14-15, 2024

    36th World Conference on Neurology

    Paris, France
    March 18-19, 2024

    28th International Conference on Neurology & Neurophysiology

    Zurich, Switzerland
    April 11-12, 2024

    36th World Congress on Neurorehabilitation

    Amsterdam, Netherlands
    April 11-12, 2024

    38th European Neurology Congress

    Amsterdam, Netherlands
    April 11-12, 2024

    36th World Neuroscience and Neurology Conferences

    Amsterdam, Netherlands
    May 30-31, 2024

    2nd International conference on Neuro Surgery

    Vienna, Austria
    June 13-14, 2024

    37th European Neurology Congress 2024

    Rome, Italy
    June 27-28, 2024

    2nd International conference on Dementia

    London, UK
    August 13-14, 2024

    14th Global Alzheimers Summit

    Amsterdam, Netherlands

    Recent Developments in Dementia Treatment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in